Virus Latency
-
Subject Areas on Research
- A neuron-specific host microRNA targets herpes simplex virus-1 ICP0 expression and promotes latency.
- A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus.
- AIDS-related cytomegalovirus retinitis: lessons from the laboratory.
- Analysis of human alphaherpesvirus microRNA expression in latently infected human trigeminal ganglia.
- Analysis of rhesus rhadinovirus microRNAs expressed in virus-induced tumors from infected rhesus macaques.
- Autophagy Genes Enhance Murine Gammaherpesvirus 68 Reactivation from Latency by Preventing Virus-Induced Systemic Inflammation.
- Combination therapy with anti-HIV-1 antibodies maintains viral suppression.
- Current issues in global tuberculosis control.
- Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
- EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival.
- Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection.
- Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.
- Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed.
- Expression of a murine cytomegalovirus early-late protein in "latently" infected mice.
- Gnidimacrin, a Potent Anti-HIV Diterpene, Can Eliminate Latent HIV-1 Ex Vivo by Activation of Protein Kinase C β.
- HIV reservoirs: the new frontier.
- HIV-1 extrachromosomal 2-LTR circular DNA is long-lived in human macrophages.
- Heterologous immunity triggered by a single, latent virus in Mus musculus: combined costimulation- and adhesion- blockade decrease rejection.
- Human papillomavirus genotype 31 does not express detectable microRNA levels during latent or productive virus replication.
- Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection.
- Identification of viral microRNAs expressed in human sacral ganglia latently infected with herpes simplex virus 2.
- In-depth analysis of Kaposi's sarcoma-associated herpesvirus microRNA expression provides insights into the mammalian microRNA-processing machinery.
- Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal Ex Vivo.
- Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.
- Latency reversal and viral clearance to cure HIV-1.
- MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs.
- Mouse cytomegalovirus reactivation in severe combined immune deficient mice after implantation of latently infected salivary gland.
- On the role of human herpesvirus 6 in viral latency in nervous tissue and in cerebral lymphoma.
- Persistently adenovirus-infected lymphoid cells express microRNAs derived from the viral VAI and especially VAII RNA.
- Prolonged clinical latency and survival of macaques given a whole inactivated simian immunodeficiency virus vaccine.
- Risk factors influencing antibody responses to Kaposi's sarcoma-associated herpesvirus latent and lytic antigens in patients under antiretroviral therapy.
- The role of microRNAs in Epstein-Barr virus latency and lytic reactivation.
- The viral and cellular microRNA targetome in lymphoblastoid cell lines.
- Three months of rifapentine and isoniazid for latent tuberculosis infection.
- To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis.
- beta-Endorphin enhances the replication of neurotropic human immunodeficiency virus in fetal perivascular microglia.
- c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
-
Keywords of People
- Luftig, Micah Alan, Associate Professor of Molecular Genetics and Microbiology, Immunology